Total pendapatan perusahaan Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical (COLL) maintains a resilient business model due to its focus on the US market, which eliminates the impact of sanctions. The company's sales volume confirms this stability, with the value of 0.82 serving as a baseline indicator. Despite global risks of raw material supply chain disruptions, Collegium Pharmaceutical is expanding its influence through partnerships with pharmacy chains and responsible medication use programs.

COLL - Pendapatan perusahaan Collegium Corp ing rentang 04.07.2022 - 14.11.2026

Rincian metrik komprehensif lan analitis Collegium Pharma (COLL)

- nilai saham lan prakiraan konsensus rega:

Kutipan saham collegiumpharma.com|COLL - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Collegium Pharmaceutical Inc|COLL - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Collegium Pharmaceutical|COLL - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku collegiumpharma.com|COLL - Total Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Utang marang Modal Collegium Pharmaceutical|COLL - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Collegium Pharmaceutical Inc|COLL - Gunggung utang perusahaan|Utang-utang marang aset resik Collegium Corp|COLL - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Collegium Pharmaceutical|Indikator likuiditas cepet collegiumpharma.com

- statistik bathi lan rasio pasar:

COLL - Penghasilan resik|Penghasilan resik sing dikarepake Collegium Pharmaceutical|COLL - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Collegium Pharmaceutical, Inc.|COLL - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Collegium Pharma|COLL - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Collegium Pharmaceutical|COLL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan collegiumpharma.com|COLL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Collegium Pharmaceutical

- indikator volume dodolan lan pendapatan:

COLL - Pendapatan lan volume dodolan|Prakiraan volume dodolan Collegium Pharmaceutical|COLL - Multiplikator P/S|Multiplikator forward rega marang pendapatan Collegium Pharma

Ringkesan analisis perusahaan:Collegium Pharmaceutical

Produk asli Collegium Pharmaceutical, Inc.

An investment audit of the issuer requires a detailed review of operational efficiency before purchasing the asset. This metric aggregates daily product sales revenue, measuring the actual pace of cash inflows. For Collegium Pharmaceutical (COLL), this reflects stable demand for mature analgesic drugs. Analyzing the company's total sales volume allows for the identification of deviations from shipment plans. Regular monitoring of the chart prevents the risk of profit shortfalls.

Perusahaan pesaing